Why relaxing is so much work.
Verified by Psychology Today
A resource for patients and families
Charles Zorumski M.D., Eugene Rubin M.D., Ph.D.
To reach the large number of individuals suffering from depression and anxiety, health care models are being implemented where psychiatrists advise primary care teams.
A recent study investigated the efficacy of deep brain stimulation for severe, treatment-refractory OCD. Over half of the participants in this study showed significant improvement.
There is a striking relationship between a history of psychiatric symptoms and the rate of aging. This relationship is clearly evident by age 45.
Although traumatic brain injury (TBI) involves brain-related symptoms, other organs including the immune system, GI system, lungs, and heart also may become compromised.
A recent paper reported that 1.7 percent of persons with schizophrenia spectrum disorders died by suicide. About half did so within five years of first diagnosis.
Although psychotic symptoms are often the most dramatic and visible features of schizophrenia, other symptoms are likely responsible for poor long-term outcomes.
Neurosurgical ablation of a specific brain area led to marked improvement in two patients suffering from both treatment-refractory epilepsy and treatment-resistant PTSD.
Two reports indicate that a single intravenous infusion of ketamine can help reduce alcohol consumption in people with problematic drinking behaviors.
The mental health consequences of the pandemic have been dramatic, and young adults are especially susceptible to anxiety and depressive symptoms.
Although the virus causing COVID-19 can directly affect the brain, psychiatric symptoms resulting from pandemic-related stressors are much more common.
Major progress is being made in developing blood tests to detect Alzheimer’s disease even in pre-symptomatic phases. This is important for several reasons.
The intersection of the COVID-19 pandemic and Black Lives Matter movement is stimulating much needed discussion and action about diversity and equity at academic medical centers.
COVID-19 can cause brain-related complications, including new-onset psychosis and strokes.
In two longitudinal studies, there was a strong association between attendance at religious services and fewer deaths related to suicide, drugs, and alcohol.
Will the COVID-19 pandemic cause physicians, medical centers, and hospitals to return to core values?
Treatment with an intensive form of TMS may lead to improvement for patients with severe, treatment-resistant depression.
COVID-19 influences brain function and can cause neurologic and psychiatric symptoms. Psychiatrists are involved in studies defining disease mechanisms and developing treatments.
Treating ADHD with stimulant medications may help reduce suicidal behavior. This effect is not observed with non-stimulant medication for ADHD.
The majority of individuals suffering from mood, anxiety, and substance use disorders do not receive any type of treatment.
Increasing evidence suggests that microbes living in our gastrointestinal system can influence brain function and behavior.
Studies indicate that a brief course of medication or brain stimulation coupled with psychological treatment may lead to relief for two complex disorders.
Young children at risk for schizophrenia have significant differences in cognitive functioning when compared to children at risk for bipolar disorder and controls.
Two recently approved antidepressant medications may represent the beginning of a second revolution in psychopharmacology.
An important study indicates that alcohol and drug use are major contributors to the overall burden of disease worldwide.
A recent study provides evidence that anorexia nervosa is both a psychiatric and metabolic disorder.
Early diagnosis of bipolar disorder is important so that appropriate treatments can be initiated. However, diagnosis can be challenging. Why?
Suicide rates in the U.S. have increased about 35 percent since the year 2000. Death rates from unintentional overdoses, however, have increased 450 percent over the same period.
When adults report being maltreated as children, are their reports always accurate? When children experience maltreatment, do they recall it later as adults?
A study of health claims data demonstrates that the use of medications to treat ADHD is associated with a decrease in later substance use-related events.
Substantial progress is being made to develop blood tests that can detect early stages of brain degeneration.
Charles F. Zorumski, MD, is Samuel B. Guze Professor and Head of Psychiatry at Washington University in St. Louis - School of Medicine.
Eugene Rubin, M.D., Ph.D., is Professor and Vice-Chair for Education in the Department of Psychiatry at Washington University in St. Louis - School of Medicine.